Skip to main content

Target-conditioned sequence generation

Scientific Design Engine · Regulatory deoxyribonucleic acid (DNA) design

TrioDNADesign regulatory DNA with explicit cell-type intent

TrioDNA connects a learned DNA sequence prior, cell-aware activity evaluation, model-guided local editing, and population selection. The output is a ranked archive that keeps target activity, off-target context, regulatory motif evidence, and sequence diversity visible.

TrioDNA yeast promoter generation-budget curves showing top score, medium score, and sequence diversity for complex and defined targets
Yeast promoter / budget sensitivity

More search raises score while population diversity narrows

The project curve keeps complex and defined promoter targets visible across six generation budgets and shows the activity–diversity trade-off directly.

Evidence boundary. Per-budget dispersion is unavailable; the figure supports within-method sensitivity only.
Design object
Regulatory DNA sequence
Condition
Requested cell type
Search
Generation plus local infill
Output
Evidence-bearing archive

01 / Abstract and project definition

Cell-Type-Aware Regulatory DNA Design

TrioDNA treats regulatory DNA design as a constrained population-search problem. Candidate sequences should remain plausible under a learned sequence prior, direct predicted activity toward a requested cell type, control off-target responses, preserve transcription-factor binding site evidence, and retain diversity across the final archive.

The method supports full-sequence generation and bounded local infill. A causal Transformer learns global and local sequence structure; cell activity measurements create directional supervision; compatible predictors return target and off-target score maps; and population search balances reward, regulatory alignment, and inter-sequence diversity.

02 / Scientific problem

A sequence can receive a high score and still be the wrong regulatory design.

One scalar objective cannot fully describe sequence plausibility, cell-type specificity, off-target behavior, transcription-factor binding site patterns, and population diversity. TrioDNA keeps these dimensions visible during generation, evaluation, and archive selection.

01 / Prior

Sequence plausibility

Candidates remain compatible with global and local statistical structure learned from the regulatory sequence corpus.

02 / Context

Cell-type specificity

Target activity is interpreted beside maximum and aggregate off-target activity and the resulting specificity margin.

03 / Regulation

Motif fidelity

Transcription-factor binding site frequency patterns provide a reference-facing constraint beyond activity alone.

04 / Population

Archive diversity

Selection returns multiple distinct high-scoring candidates rather than a single isolated optimum.

03 / Method overview

A generative prior proposes sequence variation; cell-aware and regulatory evidence determine what survives.

The tokenizer represents standard DNA bases and control tokens for autoregressive generation and fill-in-the-middle rewriting. Preference alignment biases the prior toward target-favoring sequences. Candidate batches receive cell score maps and sequence-quality audits, while population search creates local edits and selects survivors across a controlled generation budget.

01

Sequence prior

Autoregressive and fill-in-the-middle training teach full-sequence continuation and bounded local rewriting.

Output · Pretrained DNA model
02

Cell-type alignment

Activity measurements create within-split labels and preferred/rejected sequence pairs that encode directional cell intent.

Output · Aligned sequence policy
03

Generation and editing

The system samples full sequences or rewrites bounded spans while preserving sequence length and untouched context.

Output · Candidate population
04

Evaluation and selection

Activity maps, off-target summaries, sequence audits, motif correlation, reward, and diversity drive archive selection.

Output · Ranked sequence archive

04 / Architecture

Every handoff has an explicit scientific contract

Inputs, operations, evidence, and outputs stay named so the source of each decision can be reviewed.

  1. Input A

    Regulatory sequence corpus

    Normalized sequences establish the global and local sequence prior.

  2. Input B

    Cell activity measurements

    Compatible target and off-target values define directional supervision and evaluation context.

  3. Model

    DNA sequence prior

    A causal Transformer learns autoregressive continuation and fill-in-the-middle rewriting.

  4. Condition

    Cell-type intent

    Preference comparisons bias sequence likelihood toward the requested cellular context.

  5. Search

    Candidate population

    Full generation and local edits feed a population-level optimization loop.

  6. Select

    Evidence-bearing archive

    Reward, motif alignment, and sequence diversity determine the retained set.

05 / End-to-end workflow

From scientific input to an evidence-bearing decision

Each stage consumes a bounded object and leaves a reviewable artifact for the next stage.

  1. 01

    Prepare

    Normalize regulatory DNA, establish training and validation partitions, and define the sequence context.

    Prior corpus
  2. 02

    Train

    Learn full-sequence and local-span structure through autoregressive and fill-in-the-middle objectives.

    Sequence prior
  3. 03

    Align

    Convert compatible activity measurements into target-aware labels and preference comparisons.

    Labels and pairs
  4. 04

    Generate

    Sample new sequences or create bounded local edits from selected parents.

    Candidate batch
  5. 05

    Evaluate

    Score target and off-target responses and attach sequence-quality and regulatory evidence.

    Score map
  6. 06

    Search

    Select survivors, create offspring, and repeat under a controlled generation budget.

    Population history
  7. 07

    Archive

    Balance reward, motif alignment, and inter-sequence diversity under the experiment contract.

    Sequence archive

06 / Experimental design

Questions, protocols, and comparison boundaries remain attached

Every study below describes what was varied, what was measured, and where interpretation must stop.

Human enhancer

Cell-specific 200 base-pair design

For HepG2, K562, and SK-N-SH, each target and seed scores an archive of 8,192 candidates and retains 256 through motif-aware selection. Five seeds report mean and standard deviation for reward difference and motif correlation.

Cell types
3
Sequence length
200 bp
Seeds
5
Archive per target and seed
8,192 → 256
Yeast promoter

Generation-budget sensitivity

Complex and defined promoter targets are evaluated across six generation budgets. Raw top and medium activity summaries are read beside sequence diversity; 20 generations is the selected operating balance.

Targets
2
Budgets
5–100 generations
Confirmation seeds
5
Selected operating point
20 generations

07 / Results and evidence

Read the signal with its evidence boundary

Quantitative summaries, structural views, and scientific interpretation remain separate layers.

3 / 3

Enhancer dual-gate passes

TrioDNA exceeds the protocol-matched Ctrl-DNA control baseline on reward difference (ΔR) and motif correlation for every shared cell

+0.466

Largest motif-correlation gap

SK-N-SH five-seed mean difference versus the Ctrl-DNA control baseline

+2.00

Complex-target diversity gain

Five-seed mean versus the TACO reinforcement-learning promoter baseline

+4.80

Defined-target diversity gain

Five-seed mean versus the TACO reinforcement-learning promoter baseline

01

All three enhancer targets clear both matched gates

For HepG2, K562, and SK-N-SH, TrioDNA exceeds Ctrl-DNA on reward difference and transcription-factor binding site motif correlation under the same cells and evaluation protocol. The largest gaps occur for SK-N-SH: +0.084 reward difference and +0.466 motif correlation.

Boundary. These are predictor and set-level motif results; no position-level motif hits, cellular measurements, or wet-lab enhancer activity are shown.
02

Search depth increases raw score while diversity contracts

Across six budgets, complex-target raw top score rises from 20.55 to 31.70 while diversity falls from 57.0 to 52.8. Defined-target top score rises from 20.05 to 37.17 while diversity falls from 58.0 to 52.0. Twenty generations is retained as the operating balance.

Boundary. Per-budget standard deviations are unavailable in the curated snapshot, so this curve is within-method sensitivity rather than a significance analysis.
03

Protocol-matched diversity remains above TACO

In five-seed confirmation, TrioDNA diversity is 54.80 ± 2.48 for the complex target and 54.40 ± 4.41 for the defined target, compared with 52.80 ± 3.49 and 49.60 ± 1.79 for TACO.

Boundary. Only the shared diversity metric is directly comparable; the reported activity scales differ and remain separate.

Reading key

Scientific abbreviations

TFBS
Transcription-factor binding site, used here through set-level motif-frequency correlation.
ΔR
Reward difference, a target-aware activity summary used by the enhancer evaluation.
TACO
A reinforcement-learning promoter-design baseline used for the protocol-matched yeast diversity comparison.

08 / Limitations and provenance

What the current evidence can establish

Only results using compatible target models and evaluation protocols are described as direct comparisons.

01

Predictor evidence is protocol-specific

Direct comparison requires the same target models, cell definitions, sequence length, selection procedure, and evaluation protocol.

02

Some dispersion is unavailable

The yeast budget curve lacks per-budget standard deviation in the curated public snapshot.

03

Activity scales differ

TrioDNA raw oracle summaries and TACO paper-facing activity ceilings use different scales; only protocol-matched diversity is compared directly.

04

Biological validation is pending

The current evidence does not establish enhancer or promoter activity in cells, tissue specificity, safety, or therapeutic performance.